F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells

Endocrinology

Volumn 148, Issue 8, 2007, Pages 3635-3644

  Sales, Kurt J ^a   Boddy, Sheila C ^a   Williams, Alistair R W ^b   Anderson, Richard A ^a,b   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTANOID RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; SU 4984; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARCINOMA CELL; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADULT; AGED; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROST; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEEDBACK, BIOCHEMICAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PARACRINE COMMUNICATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER;

EID: 34547111277     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1517     Document Type: Article

References (30)

1. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S 1991 The epidemiology of endometrial cancer. Gynecol Oncol 41:1-16
2. Ellenson LH, Wu TC 2004 Focus on endometrial and cervical cancer. Cancer Cell 5:533-538
3. Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M 2003 Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 43:309-319
4. Rusnati M, Casarotti G, Pecorelli S, Ragnotti G, Presta M 1993 Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium. Gynecol Oncol 48:88-93
5. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, Korc M, Demopoulos RI 1994 Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 54:2347-2358
6. Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M 2003 Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162: 1913-1926
7. Kwabi-Addo B, Ozen M, Ittmann M 2004 The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11:709-724
8. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN 2002 Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 62:424-432
9. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716
10. Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN 2007 Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 22: 36-44
11. Jabbour HN, Sales KJ 2004 Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 15:398-404
12. Sales KJ, Milne SA, Williams AR, Anderson RA, Jabbour HN 2004 Expression, localization, and signaling of prostaglandin F2 α receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 89:986-993
13. Rees MC 1989 Heavy, painful periods. Baillieres Clin Obstet Gynaecol 3:341-356
14. Rees MC, Anderson AB, Demers LM, Turnbull AC 1984 Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea. Br J Obstet Gynaecol 91:673-680
15. Rees MC, Turnbull AC 1985 Leiomyomas release prostaglandins. Prostaglandins Leukot Med 18:65-68
16. Smith SK, Abel MH, Kelly RW, Baird DT 1981 Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88:434-442
17. Sales KJ, List T, Boddy SC, Williams AR, Anderson RA, Naor Z, Jabbour HN 2005 A novel angiogenic role for prostaglandin F2α-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 65:7707-7716
18. Jabbour HN, Sales KJ, Boddy SC, Anderson RA, Williams AR 2005 A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2α synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway. Endocrinology 146:4657-4664
19. Noyes RW, Hertig AT, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
20. Milne SA, Jabbour HN 2003 Prostaglandin (PG) F2α receptor expression and signaling in human endometrium: role of PGF2α in epithelial cell proliferation. J Clin Endocrinol Metab 88:1825-1832
21. Sales KJ, Maudsley S, Jabbour HN 2004 Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Endocrinol 18:1533-1545
22. Seno H, Oshima M, Ishikawa T, Oshima H, Takaku K, Chiba T, Narumiya S, Taketo MM 2002 Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in APC delta 716 Mouse intestinal polyps. Cancer Res 62:506-511
23. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M, Taketo MM 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat Med 7:1048-1051
24. Chang SH, Ai Y, Breyer RM, Lane TF, Hla T 2005 The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res 65:4496-4499
25. Niho N, Mutoh M, Kitamura T, Takahashi M, Sato H, Yamamoto H, Maruyama T, Ohuchida S, Sugimura T, Wakabayashi K 2005 Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist. Cancer Sci 96:260-264
26. Hull MA, Ko SC, Hawcroft G 2004 Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther 3:1031-1039
27. Feng S, Wang F, Matsubara A, Kan M, McKeehan WL 1997 Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Cancer Res 57:5369-5378
28. Welm BE, Freeman KW, Chen M, Contreras A, Spencer DM, Rosen JM 2002 Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol 157:703-714
29. Yamazaki K, Nagao T, Yamaguchi T, Saisho H, Kondo Y 1997 Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma. Virchows Arch 431:95-101
30. Wang Y, Becker D 1997 Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 3:887-893